Financial results - Z GROUP PHARMA SRL

Financial Summary - Z Group Pharma Srl
Unique identification code: 13669440
Registration number: J39/17/2001
Nace: 8299
Sales - Ron
-
Net Profit - Ron
15.790
Employees
Open Account
Company Z Group Pharma Srl with Fiscal Code 13669440 recorded a turnover of 2024 of - , with a net profit of 15.790 and having an average number of employees of - . The company operates in the field of Alte activităţi de servicii suport pentru întreprinderi n.c.a. having the NACE code 8299.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Z Group Pharma Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 2.373 2.892 1.877 0 0 0 0 0 0 0
Total Income - EUR 11.407 54.781 2.485 416 22.066 0 41.856 0 0 19.117
Total Expenses - EUR 6.193 4.566 4.849 3.812 3.257 31.693 2.067 1.485 61 636
Gross Profit/Loss - EUR 5.214 50.215 -2.364 -3.397 18.809 -31.693 39.790 -1.485 -61 18.481
Net Profit/Loss - EUR 5.137 50.128 -2.438 -3.397 18.809 -31.693 39.776 -1.485 -61 15.790
Employees 1 0 1 0 1 0 1 1 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Z Group Pharma Srl

Rating financiar

Financial Rating -
Z GROUP PHARMA SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Z Group Pharma Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Z Group Pharma Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Z Group Pharma Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Z Group Pharma Srl - CUI 13669440

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 0 0 0 0 0 0 0 0 0 0
Current Assets 428.104 478.696 473.375 438.774 459.298 421.943 454.431 455.841 454.398 513.217
Inventories 0 0 0 0 0 0 0 0 0 0
Receivables 1.800 3.479 3.764 727 891 892 1.014 1.017 1.025 1.092
Cash 426.304 475.217 469.611 438.047 458.407 421.050 453.418 454.824 453.373 512.125
Shareholders Funds 351.648 398.189 389.013 353.101 371.939 334.682 367.036 366.690 365.517 420.870
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 76.456 80.507 84.362 85.674 87.358 87.261 87.395 89.151 88.881 92.347
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8299 - 8299"
CAEN Financial Year 8299
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 513.217 euro in 2024 which includes Inventories of 0 euro, Receivables of 1.092 euro and cash availability of 512.125 euro.
The company's Equity was valued at 420.870 euro, while total Liabilities amounted to 92.347 euro. Equity increased by 57.396 euro, from 365.517 euro in 2023, to 420.870 in 2024.

Risk Reports Prices

Reviews - Z Group Pharma Srl

Comments - Z Group Pharma Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.